Biomimic Nanodrugs Overcome Tumor Immunosuppressive Microenvironment to Enhance Cuproptosis/Chemodynamic‐Induced Cancer Immunotherapy
Advanced Science · 2025-02 · 12 (5)
DOI: 10.1002/advs.202411122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 12.12.2024. Verfasst von Hangyi Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, China Pharmaceutical University, Nanjing, Jiangsu, 211198, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Immunotherapy, Copper, Neoplasms. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Jiangsu Funding Program for Excellent Postdoctoral Talent (China), Jiangsu Province "333" project for excellent young scholars, Suqian Science and Technology P….
Abstract (Originalsprache)
Elesclomol (ES) as an efficient Cu ionophore can specifically transport Cu into mitochondria and disrupt intracellular Cu homeostasis. Extra intracellular Cu induces cuproptosis and chemodynamic therapy (CDT), which further cascades immunogenic cell death (ICD) and activates antitumor immune responses. However, the tumor immunosuppressive microenvironment (TIM) attenuates the efficiency of the immune response. Herein, a biomimic nanodrug (ECNM) is fabricated, of which ES, Cu 2+ and NLG919 (an IDO1 inhibitor) are integrated via a self‐assembly process and subsequently coated with 4T1 cell membrane. ECNM can overcome the typical drawbacks of ES, ameliorating the stability and half‐life of ES by membrane‐coating and enhancing its tumor accumulation and internalization via homotypic targeting. It is worth mentioning that, the addition of NLG919 is also beneficial to the system circulation stability of ES and reduces the non‐specific ES release. After internalization, ECNM dissociates via the glutathione‐responsive process and exhibits comprehensive antitumor capabilities, including cuproptosis, CDT and TIM reversing, thereby eliciting ICD and optimizing the antitumor immune response. Furthermore, ECNM not only accelerates tumor regression but also gains a strong abscopal effect and displays the potential of tumor vaccination. Overall, ECNM can activate antitumor immunity via cuproptosis and CDT, together with TIM reversing, for cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, China Pharmaceutical University, Nanjing, Jiangsu, 211198, China.
- Phase I clinical trial center, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, Jiangsu, 215000, China.
- Department of Pharmaceutics, The affiliated Suqian First People's Hospital of Nanjing Medical University, Suqian, Jiangsu, 223800, China.
ORCID-Profile: Huixia Lv
Förderung
- National Natural Science Foundation of China
- Jiangsu Funding Program for Excellent Postdoctoral Talent (China), Jiangsu Province "333" project for excellent young scholars, Suqian Science and Technology P…
Zitieren
APA
Wu, H., Lu, X., Hu, Y., Baatarbolat, J., Zhang, Z., Liang, Y., Zhang, Y., Liu, Y., Lv, H., & Jin, X. (2025). Biomimic Nanodrugs Overcome Tumor Immunosuppressive Microenvironment to Enhance Cuproptosis/Chemodynamic‐Induced Cancer Immunotherapy. Advanced Science, 12(5). https://doi.org/10.1002/advs.202411122
Vancouver
Wu H, Lu X, Hu Y, Baatarbolat J, Zhang Z, Liang Y, et al. Biomimic Nanodrugs Overcome Tumor Immunosuppressive Microenvironment to Enhance Cuproptosis/Chemodynamic‐Induced Cancer Immunotherapy. Advanced Science. 2025;12(5). doi:10.1002/advs.202411122
BibTeX
@article{Wu2025,
author = {Wu, Hangyi and Lu, Xiaoyu and Hu, Yuhan and Baatarbolat, J and Zhang, Zhihao and Liang, Yiping and Zhang, Youwen and Liu, Ye and Lv, Huixia and Jin, Xin},
title = {Biomimic Nanodrugs Overcome Tumor Immunosuppressive Microenvironment to Enhance Cuproptosis/Chemodynamic‐Induced Cancer Immunotherapy},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {5},
doi = {10.1002/advs.202411122}
}
EUVIMED